代代谢物R-2-基酸盐通过FTO/NF-κB通路抑制微质激活
Lu Wang1, Huiting Zhang1, Xifeng Jing1
1Hematology Center, Cyrus Tang Medical Institute, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematological Diseases, Soochow University, Suzhou, China.
Frontiers in oncology
|December 10, 2025
概括
突变IDH1产生R-2HG,它通过抑制FTO/NF-κB通路来抑制微质IL-6的产生. 这一发现揭示了R-2HG在调节质瘤免疫微环境中的新机制.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 异酸脱酶1 (mIDH1) 中的突变会产生代代谢物 (R) - 2 - 2 - 基酸盐 (R-2HG).
- R-2HG 改变了表观遗传特征,并损害了 CD8+ T 细胞的功能.
- 微质细胞是质瘤中关键的免疫细胞,但R-2HG对它们的影响尚不清楚.
研究的目的:
- 研究R-2HG对微质炎症反应的影响.
- 确定R-2HG对微质中的IL-6产生的特定影响.
- 阐明R-2HG对微质细胞作用的潜在分子机制.
主要方法:
- 利用小鼠微质BV2细胞系用质瘤条件介质 (CM) 刺激.
- 分析了细胞因子的产生 (重点是IL-6) 和NF-κB通路的激活 (IκBα和p65酸化/转移).
- 评估了α-谷氨酸补充剂和RNA脱甲基酶FTO的作用.
主要成果:
- 在BV2细胞中,R-2HG特别抑制了CM诱导的IL-6产生.
- 通过抑制IκBα酸化和p65核转位,R-2HG抑制了NF-κB通路的激活.
- R-2HG对IL-6的抑制作用被α-甲酸逆转,并通过FTO抑制进行中介.
结论:
- R-2HG通过FTO/NF-κB信号通路抑制微质炎症激活,减少IL-6的产生.
- 这项研究揭示了R-2HG在调节瘤免疫微环境中的新机制.
- 这些发现为IDH突变质瘤的抗瘤免疫提供了洞察力.
更多相关视频
相关概念视频
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Drugs that Stabilize Microtubules
2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K


